Healthcare Services

A key trend shaping the Human Liver Model Market involves the Advanced System To Enhance Adoption Of Predictive Human Liver Models

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Human Liver Model Market By 2030 Starting From Its 2026 Size?

The human liver model market has shown significant expansion in recent years. It is anticipated to increase from $2.62 billion in 2025 to $2.98 billion in 2026, progressing at a compound annual growth rate (CAGR) of 13.5%. This historical growth can be primarily linked to several factors: a rise in drug attrition caused by liver toxicity, the inherent constraints of traditional animal models, an increase in pharmaceutical research and development activities, the early adoption of 2D liver cell culture models, and a growing emphasis on evaluating drug safety.

The human liver model market is projected to undergo significant growth in the upcoming years, with its valuation expected to reach $5.02 billion by 2030, reflecting a compound annual growth rate (CAGR) of 14.0%. This expansion during the forecast period is fueled by an escalating need for precision toxicology models, the development of organ-on-chip technologies, a heightened regulatory focus on minimizing animal testing, increased investments in advanced in vitro research tools, and a broader application of human-relevant models in early drug development phases. Prominent trends observed during this period encompass the greater adoption of sophisticated in vitro liver models for toxicity evaluations, the increasing utilization of liver organoids in drug discovery pipelines, a growing preference for human-relevant models over animal testing, the expanded use of liver-on-a-chip applications in preclinical research, and a rising demand for predictive hepatotoxicity assessment instruments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Human Liver Model Market?

A rise in clinical trials is anticipated to boost the expansion of the human liver model market in the future. These trials are research endeavors undertaken to assess the safety and effectiveness of medical procedures, therapies, or medications in human subjects. Within clinical trials, human liver models find application in simulating and examining drug metabolism and liver toxicity, crucial for pharmaceutical advancement. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, revealed that the total number of clinical trials launched in the UK climbed from 411 in 2022 to 426 in 2023. Consequently, the growing number of clinical trials is fueling the human liver model market.

Which Segment Categories Define The Human Liver Model Market?

The human liver model market covered in this report is segmented –

1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, 3D Bioprinting

2) By Application: Educational, Drug Discovery, Other Applications

3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Liver Organoids: Primary Liver Organoids, Induced Pluripotent Stem Cell (iPSC)-Derived Organoids

2) By Liver-On-A-Chip: Microfluidic Liver Chips, Multi-Organ Chip Systems

3) By 2D Models: Liver Cell Cultures, Liver Cell Lines

4) By 3D Bioprinting: Bioprinted Liver Tissues, Hybrid Bioprinted Models

What Key Trends Are Influencing The Development Of The Human Liver Model Market?

Major companies in the human liver model market are concentrating on developing sophisticated systems, such as single-organ higher throughput (HT) systems, to improve the acceptance of predictive human liver models and gain a competitive edge. A single-organ higher throughput (HT) system is a technology designed for scalable and cost-effective drug discovery, specifically overcoming obstacles related to the adoption of predictive human liver models. For example, in February 2023, CN Bio, a UK-based organ-on-a-chip company, unveiled PhysioMimix with Liver-48 plate, which is a single-organ higher throughput (HT) system developed to address barriers hindering the use of predictive human liver models in drug discovery. This technology offers a scalable and cost-effective solution, enabling researchers to conduct larger-scale comparative studies on drug disposition, efficacy, or safety. The Liver-48 plate itself is a multi-chip consumable that miniaturizes the company’s human liver model for applications including forecasting drug-induced liver injury and assessing drug metabolism.

Who Are The Top Companies Competing In The Human Liver Model Market?

Major companies operating in the human liver model market are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.

Read the full human liver model market report here:

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Which Regions Are Projected To Dominate The Human Liver Model Market In The Coming Years?

North America was the largest region in the human liver model market in 2025. The regions covered in the human liver model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Human Liver Model Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12244&type=smp

Browse Through More Reports Similar to the Global Human Liver Model Market 2026, By The Business Research Company

Rat Model Global Market Report

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

Anatomical Models Global Market Report

https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report

Liver Diseases Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795